Location History:
- Staffordshire, GB (2009)
- Keele, GB (2011 - 2014)
Company Filing History:
Years Active: 2009-2014
Title: Innovations of Rocky Marc Cranenburgh
Introduction
Rocky Marc Cranenburgh is an accomplished inventor based in Keele, GB. He has made significant contributions to the field of biotechnology, particularly in the development of plasmid technologies. With a total of 3 patents to his name, Cranenburgh's work focuses on enhancing the efficiency and safety of genetic engineering processes.
Latest Patents
Cranenburgh's latest patents include a groundbreaking method for producing a selectable marker gene-free plasmid. This method involves culturing a plasmid containing a selectable marker gene flanked by site-specific recombinase target sites in a host cell environment that cannot effect recombination. Subsequently, the plasmid is cultured in another host cell environment capable of recombination, allowing for the excision of the selectable marker gene. This innovation has significant applications in the production of recombinant proteins for therapeutic and vaccine purposes, as well as in the delivery of DNA to patients using live bacterial vectors.
Another notable patent is the process for the removal of selectable marker gene sequences, particularly antibiotic gene sequences, from nucleic acid molecules. This invention is crucial for the unlabelled integration and deletion of chromosomal genes and for controlling gene expression, thereby enhancing the precision of genetic modifications.
Career Highlights
Throughout his career, Cranenburgh has worked with prominent companies in the biotechnology sector, including Cobra Biologics Limited and Boehringer Ingelheim Rcv GmbH & Co. Kg. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance the field of genetic engineering.
Collaborations
Cranenburgh has collaborated with notable professionals in his field, including Matthew William Leckenby and Alexandra Elizabeth Bloor. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Rocky Marc Cranenburgh's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches to plasmid technology continue to pave the way for advancements in genetic engineering and therapeutic applications.